Deregulation of calcium fluxes in HTLV-I infected CD4-positive T-cells plays a major role in malignant transformation

Frontiers in Bioscience

Volumn 14, Issue 10, 2009, Pages 3925-3934

  Akl, Haidar ^a   Badran, Bassam ^a   Zein, Nabil El ^b   Dobirta, Gratiela ^a   Burny, Arsène ^a   Martiat, Philippe ^a  

^a JULES BORDET INSTITUTE   (Belgium)

^b Hôpital des Enfants   (Belgium)

Author keywords

Akt; bad; HTLV I; PI3K; Review; TCR CD3,CD7

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1;

CALCIUM; LYMPHOCYTE ANTIGEN RECEPTOR; P12I PROTEIN, HUMAN T LYMPHOTROPIC VIRUS 1; P12I PROTEIN, HUMAN T-LYMPHOTROPIC VIRUS 1; VIRUS PROTEIN;

CD4+ T LYMPHOCYTE; CELL TRANSFORMATION; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; METABOLISM; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; VIROLOGY;

CALCIUM; CD4-POSITIVE T-LYMPHOCYTES; CELL TRANSFORMATION, NEOPLASTIC; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; VIRAL REGULATORY AND ACCESSORY PROTEINS;

EID: 63849255129     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2735/3501     Document Type: Article

References (114)

1. M. J. Berridge, P. Lipp and M. D. Bootman: The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol 1, 11-21(2000)
2. M. J. Berridge, M. D. Bootman and H. L. Roderick: Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol 4, 517-529(2003) (Pubitemid 36773404)
3. M. J. Berridge: The 1996 Massry Prize. Inositol trisphosphate and calcium: two interacting second messengers. Am J Nephrol 17, 1-11(1997)
4. R. S. Lewis: Calcium oscillations in T-cells: mechanisms and consequences for gene expression. Biochem Soc Trans 31, 925-929(2003) (Pubitemid 37305018)
5. E. M. Gallo, K. Cante-Barrett and G. R. Crabtree: Lymphocyte calcium signaling from membrane to nucleus. Nat Immunol 7, 25-32(2006) (Pubitemid 41823865)
6. 2+ signalling". Biol Cell 96, 69-78(2004) (Pubitemid 38240400)
7. 2+ response amplitude and duration. Nature 386, 855-858(1997) (Pubitemid 27181262)
8. R. E. Dolmetsch, K. Xu and R. S. Lewis: Calcium oscillations increase the efficiency and specificity of gene expression. Nature 392, 933-936(1998) (Pubitemid 28232066)
9. N. D. Collins, G. C. Newbound, B. Albrecht, J. L. Beard, L. Ratner and M. D. Lairmore: Selective ablation of human T-cell lymphotropic virus type 1 p12I reduces viral infectivity in vivo. Blood 91, 4701-4707(1998) (Pubitemid 28270320)
10. B. Albrecht, N. D. Collins, M. T. Burniston, J. W. Nisbet, L. Ratner, P. L. Green and M. D. Lairmore: Human T-lymphotropic virus type 1 open reading frame I p12 (I) is required for efficient viral infectivity in primary lymphocytes. J Virol 74, 9828-9835(2000)
11. C. Nicot, R. L. Harrod, V. Ciminale and G. Franchini: Human T-cell leukemia/lymphoma virus type 1 nonstructural genes and their functions. Oncogene 24, 6026-6034(2005) (Pubitemid 43086120)
12. W. Ding, B. Albrecht, R. Luo, W. Zhang, J. R. Stanley, G. C. Newbound and M. D. Lairmore: Endoplasmic reticulum and cis-Golgi localization of human T-lymphotropic virus type 1 p12 (I): association with calreticulin and calnexin. J Virol 75, 7672-7682(2001) (Pubitemid 32738025)
13. S. J. Kim, A. M. Nair, S. Fernandez, L. Mathes and M. D. Lairmore: Enhancement of LFA-1-mediated T cell adhesion by human T lymphotropic virus type 1 p12I1. J Immunol 176, 5463-5470(2006)
14. A. M. Nair, B. Michael, A. Datta, S. Fernandez and M. D. Lairmore: Calcium-dependent enhancement of transcription of p300 by human T-lymphotropic type 1 p12I. Virology 353, 247-257(2006) (Pubitemid 44397141)
15. A. Nair, B. Michael, H. Hiraragi, S. Fernandez, G. Feuer, K. Boris-Lawrie and M. Lairmore: Human T lymphotropic virus type 1 accessory protein p12I modulates calciummediated cellular gene expression and enhances p300 expression in T lymphocytes. AIDS Res Hum Retroviruses 21, 273-284(2005) (Pubitemid 40632359)
16. B. Albrecht, C. D. D'Souza, W. Ding, S. Tridandapani, K. M. Coggeshall and M. D. Lairmore: Activation of nuclear factor of activated T cells by human T-lymphotropic virus type 1 accessory protein p12 (I) J Virol 76, 3493-3501(2002) (Pubitemid 34224550)
17. S. J. Kim, W. Ding, B. Albrecht, P. L. Green and M. D. Lairmore: A conserved calcineurin-binding motif in human T lymphotropic virus type 1 p12I functions to modulate nuclear factor of activated T cell activation. J Biol Chem 278, 15550-15557(2003) (Pubitemid 36799662)
18. W. Ding, B. Albrecht, R. E. Kelley, N. Muthusamy, S. J. Kim, R. A. Altschuld and M. D. Lairmore: Human T-cell lymphotropic virus type 1 p12 (I) expression increases cytoplasmic calcium to enhance the activation of nuclear factor of activated T cells. J Virol 76, 10374-10382(2002)
19. R. Fukumoto, M. Dundr, C. Nicot, A. Adams, V. W. Valeri, L. E. Samelson and G. Franchini: Inhibition of T-cell receptor signal transduction and viral expression by the linker for activation of T cells-interacting p12 (I) protein of human T-cell leukemia/lymphoma virus type 1. J Virol 81, 9088-9099(2007) (Pubitemid 47311452)
20. R. Fukumoto, M. Dundr, C. Nicot, A. Adams, V. W. Valeri, L. E. Samelson and G. Franchini: Inhibition of T-cell receptor signal transduction and viral expression by the linker for activation of T cells-interacting p12 (I) protein of human T-cell leukemia/lymphoma virus type 1. J Virol 81, 9088-9099(2007) (Pubitemid 47311452)
21. J. M. Johnson, C. Nicot, J. Fullen, V. Ciminale, L. Casareto, J. C. Mulloy, S. Jacobson and G. Franchini: Free major histocompatibility complex class I heavy chain is preferentially targeted for degradation by human T-cell leukemia/lymphotropic virus type 1 p12 (I) protein. J Virol 75, 6086-6094(2001) (Pubitemid 32553139)
22. D. M. D'Agostino, M. Silic-Benussi, H. Hiraragi, M. D. Lairmore and V. Ciminale: The human T-cell leukemia virus type 1 p13II protein: effects on mitochondrial function and cell growth. Cell Death Differ 12 Suppl 1, 905-915(2005) (Pubitemid 41030605)
23. A. Weiss and D. R. Littman: Signal transduction by lymphocyte antigen receptors. Cell 76, 263-274(1994) (Pubitemid 24046689)
24. M. Baniyash, P. Garcia-Morales, J. S. Bonifacino, L. E. Samelson and R. D. Klausner: Disulfide linkage of the zeta and eta chains of the T cell receptor. Possible identification of two structural classes of receptors. J Biol Chem 263, 9874-9878(1988)
25. B. Alarcon, B. Berkhout, J. Breitmeyer and C. Terhorst: Assembly of the human T cell receptor-CD3 complex takes place in the endoplasmic reticulum and involves intermediary complexes between the CD3-gamma.delta.epsilon core and single T cell receptor alpha or beta chains. J Biol Chem 263, 2953-2961(1988) (Pubitemid 18062950)
26. B. Berkhout, B. Alarcon and C. Terhorst: Transfection of genes encoding the T cell receptor-associated CD3 complex into COS cells results in assembly of the macromolecular structure. J Biol Chem 263, 8528-8536(1988)
27. M. Iwashima, B. A. Irving, N. S. van Oers, A. C. Chan and A. Weiss: Sequential interactions of the TCR with two distinct cytoplasmic tyrosine kinases. Science 263, 1136-1139(1994) (Pubitemid 24105959)
28. S. M. Neudorf, M. M. Jones, B. M. McCarthy, J. A. Harmony and E. M. Choi: The CD4 molecule transmits biochemical information important in the regulation of T lymphocyte activity. Cell Immunol 125, 301-314(1990) (Pubitemid 20058490)
29. N. A. Clipstone and G. R. Crabtree: Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature 357, 695-697(1992)
30. G. R. Crabtree and N. A. Clipstone: Signal transmission between the plasma membrane and nucleus of T lymphocytes. Annu Rev Biochem 63, 1045-1083(1994) (Pubitemid 24218655)
31. J. P. Northrop, S. N. Ho, L. Chen, D. J. Thomas, L. A. Timmerman, G. P. Nolan, A. Admon and G. R. Crabtree: NF-AT components define a family of transcription factors targeted in T-cell activation. Nature 369, 497-502(1994)
32. T. Yokote, T. Akioka, S. Oka, S. Hara, K. Kobayashi, H. Nakajima, T. Yamano, T. Ikemoto, A. Shimizu, M. Tsuji and T. Hanafusa: Flow cytometric immunophenotyping of adult T-cell leukemia/lymphoma using CD3 gating. Am J Clin Pathol 124, 199-204(2005) (Pubitemid 41060129)
33. H. Tsuda and K. Takatsuki: Specific decrease in T3 antigen density in adult T-cell leukaemia cells: I. Flow microfluorometric analysis. Br J Cancer 50, 843-845(1984) (Pubitemid 15221453)
34. M. Matsuoka, T. Hattori, T. Chosa, H. Tsuda, S. Kuwata, M. Yoshida, T. Uchiyama and K. Takatsuki: T3 surface molecules on adult T cell leukemia cells are modulated in vivo. Blood 67, 1070-1076(1986) (Pubitemid 16116421)
35. H. Yssel, M. R. de Waal, D. Duc, D. Blanchard, L. Gazzolo, J. E. de Vries and H. Spits: Human T cell leukemia/lymphoma virus type I infection of a CD4+ proliferative/cytotoxic T cell clone progresses in at least two distinct phases based on changes in function and phenotype of the infected cells. J Immunol 142, 2279-2289(1989) (Pubitemid 19098236)
36. M. de Waal, H. Yssel, H. Spits, J. E. de Vries, J. Sancho, C. Terhorst and B. Alarcon: Human T cell leukemia virus type I prevents cell surface expression of the T cell receptor through down-regulation of the CD3-gamma,-delta,-epsilon, and-zeta genes. J Immunol 145, 2297-2303(1990) (Pubitemid 20343399)
37. H. Akl, B. Badran, G. Dobirta, G. Manfouo-Foutsop, M. Moschitta, M. Merimi, A. Burny, P. Martiat and K. E. Willard-Gallo: Progressive loss of CD3 expression after HTLV-I infection results from chromatin remodeling affecting all the CD3 genes and persists despite early viral genes silencing. Virol J 4, 85(2007)
38. F. Le Deist, G. Thoenes, J. Corado, B. Lisowska-Grospierre and A. Fischer: Immunodeficiency with low expression of the T cell receptor/CD3 complex. Effect on T lymphocyte activation. Eur J Immunol 21, 1641-1647(1991)
39. A. Rao, C. Luo and P. G. Hogan: Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol 15, 707-747(1997) (Pubitemid 27169297)
40. F. Shibasaki, E. R. Price, D. Milan and F. McKeon: Role of kinases and the phosphatase calcineurin in the nuclear shuttling of transcription factor NF-AT4. Nature 382, 370-373(1996) (Pubitemid 26260467)
41. J. P. Northrop, S. N. Ho, L. Chen, D. J. Thomas, L. A. Timmerman, G. P. Nolan, A. Admon and G. R. Crabtree: NF-AT components define a family of transcription factors targeted in T-cell activation. Nature 369, 497-502(1994)
42. W. M. Flanagan, B. Corthesy, R. J. Bram and G. R. Crabtree: Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature 352, 803-807(1991) (Pubitemid 21912434)
43. K. T. Shaw, A. M. Ho, A. Raghavan, J. Kim, J. Jain, J. Park, S. Sharma, A. Rao and P. G. Hogan: Immunosuppressive drugs prevent a rapid dephosphorylation of transcription factor NFAT1 in stimulated immune cells. Proc Natl Acad Sci U S A 92, 11205-11209(1995)
44. C. Loh, J. A. Carew, J. Kim, P. G. Hogan and A. Rao: T-cell receptor stimulation elicits an early phase of activation and a later phase of deactivation of the transcription factor NFAT1. Mol Cell Biol 16, 3945-3954(1996) (Pubitemid 26199914)
45. C. Loh, K. T. Shaw, J. Carew, J. P. Viola, C. Luo, B. A. Perrino and A. Rao: Calcineurin binds the transcription factor NFAT1 and reversibly regulates its activity. J Biol Chem 271, 10884-10891(1996) (Pubitemid 26145827)
46. H. Medyouf, H. Alcalde, C. Berthier, M. C. Guillemin, N. R. dos Santos, A. Janin, D. Decaudin, T. H. de and J. Ghysdael: Targeting calcineurin activation as a therapeutic strategy for T-cell acute lymphoblastic leukemia. Nat Med 13, 736-741(2007) (Pubitemid 46889757)
47. L. Good, S. B. Maggirwar and S. C. Sun: Activation of the IL-2 gene promoter by HTLV-I tax involves induction of NF-AT complexes bound to the CD28-responsive element. EMBO J 15, 3744-3750(1996) (Pubitemid 26239787)
48. B. Albrecht, C. D. D'Souza, W. Ding, S. Tridandapani, K. M. Coggeshall and M. D. Lairmore: Activation of nuclear factor of activated T cells by human T-lymphotropic virus type 1 accessory protein p12 (I) J Virol 76, 3493-3501(2002) (Pubitemid 34224550)
49. S. K. Arya, R. C. Gallo, B. H. Hahn, G. M. Shaw, M. Popovic, S. Z. Salahuddin and F. Wong-Staal: Homology of genome of AIDS-associated virus with genomes of human T-cell leukemia viruses. Science 225, 927-930(1984) (Pubitemid 14064172)
50. Y. Satou, J. Yasunaga, M. Yoshida and M. Matsuoka: HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells. Proc Natl Acad Sci U S A 103, 720-725(2006) (Pubitemid 43153092)
51. Y. Taniguchi, K. Nosaka, J. Yasunaga, M. Maeda, N. Mueller, A. Okayama and M. Matsuoka: Silencing of human T-cell leukemia virus type I gene transcription by epigenetic mechanisms. Retrovirology 2, 64(2005)
52. T. Koiwa, A. Hamano-Usami, T. Ishida, A. Okayama, K. Yamaguchi, S. Kamihira and T. Watanabe: 5'-long terminal repeat-selective CpG methylation of latent human T-cell leukemia virus type 1 provirus in vitro and in vivo. J Virol 76, 9389-9397(2002) (Pubitemid 34919896)
53. G. J. Narlikar, H. Y. Fan and R. E. Kingston: Cooperation between complexes that regulate chromatin structure and transcription. Cell 108, 475-487(2002) (Pubitemid 34260873)
54. M. Lachner, R. J. O'Sullivan and T. Jenuwein: An epigenetic road map for histone lysine methylation. J Cell Sci 116, 2117-2124(2003) (Pubitemid 36722358)
55. L. M. Carruthers and J. C. Hansen: The core histone N termini function independently of linker histones during chromatin condensation. J Biol Chem 275, 37285-37290(2000) (Pubitemid 32002152)
56. A. Eberharter and P. B. Becker: Histone acetylation: a switch between repressive and permissive chromatin. Second in review series on chromatin dynamics. EMBO Rep 3, 224-229(2002) (Pubitemid 34269514)
57. G. J. Narlikar, H. Y. Fan and R. E. Kingston: Cooperation between complexes that regulate chromatin structure and transcription. Cell 108, 475-487(2002) (Pubitemid 34260873)
58. I. Lemasson, N. J. Polakowski, P. J. Laybourn and J. K. Nyborg: Transcription factor binding and histone modifications on the integrated proviral promoter in human T-cell leukemia virus-I-infected T-cells. J Biol Chem 277, 49459-49465(2002) (Pubitemid 36014381)
59. H. Lu, C. A. Pise-Masison, R. Linton, H. U. Park, R. L. Schiltz, V. Sartorelli and J. N. Brady: Tax relieves transcriptional repression by promoting histone deacetylase 1 release from the human T-cell leukemia virus type 1 long terminal repeat. J Virol 78, 6735-6743(2004) (Pubitemid 38781510)
60. T. Ego, Y. Ariumi and K. Shimotohno: The interaction of HTLV-1 Tax with HDAC1 negatively regulates the viral gene expression. Oncogene 21, 7241-7246(2002) (Pubitemid 35305612)
61. N. Mori, T. Matsuda, M. Tadano, T. Kinjo, Y. Yamada, K. Tsukasaki, S. Ikeda, Y. Yamasaki, Y. Tanaka, T. Ohta, T. Iwamasa, M. Tomonaga and N. Yamamoto: Apoptosis induced by the histone deacetylase inhibitor FR901228 in human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells. J Virol 78, 4582-4590(2004) (Pubitemid 38501079)
62. P. Viatour, S. Legrand-Poels, L. C. van, M. Warnier, M. P. Merville, J. Gielen, J. Piette, V. Bours and A. Chariot: Cytoplasmic IkappaBalpha increases NF-kappaB-independent transcription through binding to histone deacetylase (HDAC) 1 and HDAC3. J Biol Chem 278, 46541-46548(2003) (Pubitemid 37452227)
63. K. L. Konesky, J. K. Nyborg and P. J. Laybourn: Tax abolishes histone H1 repression of p300 acetyltransferase activity at the human T-cell leukemia virus type 1 promoter. J Virol 80, 10542-10553(2006) (Pubitemid 44628901)
64. S. J. Jeong, H. Lu, W. K. Cho, H. U. Park, C. Pise-Masison and J. N. Brady: Coactivator-associated arginine methyltransferase 1 enhances transcriptional activity of the human T-cell lymphotropic virus type 1 long terminal repeat through direct interaction with Tax. J Virol 80, 10036-10044(2006) (Pubitemid 44522597)
65. A. Kirmizis, H. Santos-Rosa, C. J. Penkett, M. A. Singer, M. Vermeulen, M. Mann, J. Bahler, R. D. Green and T. Kouzarides: Arginine methylation at histone H3R2 controls deposition of H3K4 trimethylation. Nature 449, 928-932(2007) (Pubitemid 47598603)
66. T. Tarkka, J. Oikarinen and T. Grundstrom: Nucleotide and calcium-induced conformational changes in histone H1. FEBS Lett 406, 56-60(1997) (Pubitemid 27156957)
67. K. Zhao, W. Wang, O. J. Rando, Y. Xue, K. Swiderek, A. Kuo and G. R. Crabtree: Rapid and phosphoinositoldependent binding of the SWI/SNF-like BAF complex to chromatin after T lymphocyte receptor signaling. Cell 95, 625-636(1998) (Pubitemid 28544124)
68. F. J. Davis, M. Gupta, B. Camoretti-Mercado, R. J. Schwartz and M. P. Gupta: Calcium/calmodulin-dependent protein kinase activates serum response factor transcription activity by its dissociation from histone deacetylase, HDAC4. Implications in cardiac muscle gene regulation during hypertrophy. J Biol Chem 278, 20047-20058(2003) (Pubitemid 36799198)
69. E. Baker, M. S. Sandrin, O. M. Garson, G. R. Sutherland, I. F. McKenzie and L. M. Webber: Localization of the cell surface antigen CD7 by chromosomal in situ hybridization. Immunogenetics 31, 412-413(1990) (Pubitemid 20199994)
70. L. E. Schanberg, D. E. Fleenor, J. Kurtzberg, B. F. Haynes and R. E. Kaufman: Isolation and characterization of the genomic human CD7 gene: structural similarity with the murine Thy-1 gene. Proc Natl Acad Sci U S A 88, 603-607(1991) (Pubitemid 21915514)
71. L. K. Jung, S. M. Fu, T. Hara, N. Kapoor and R. A. Good: Defective expression of T cell-associated glycoprotein in severe combined immunodeficiency. J Clin Invest 77, 940-946(1986) (Pubitemid 16067968)
72. K. E. Pace, H. P. Hahn, M. Pang, J. T. Nguyen and L. G. Baum: CD7 delivers a pro-apoptotic signal during galectin-1-induced T cell death. J Immunol 165, 2331-2334(2000) (Pubitemid 30660673)
73. G. Rappl, H. Abken, J. M. Muche, W. Sterry, W. Tilgen, S. Andre, H. Kaltner, S. Ugurel, H. J. Gabius and U. Reinhold: CD4+CD7-leukemic T cells from patients with Sezary syndrome are protected from galectin-1-triggered T cell death. Leukemia 16, 840-845(2002) (Pubitemid 34537556)
74. C. Morimoto, T. Matsuyama, C. Oshige, H. Tanaka, T. Hercend, E. L. Reinherz and S. F. Schlossman: Functional and phenotypic studies of Japanese adult T cell leukemia cells. J Clin Invest 75, 836-843(1985) (Pubitemid 15111006)
75. L. Dahmoush, Y. Hijazi, E. Barnes, M. Stetler-Stevenson and A. Abati: Adult T-cell leukemia/lymphoma: a cytopathologic, immunocytochemical, and flow cytometric study. Cancer 96, 110-116(2002) (Pubitemid 34438652)
76. Q. Xu, S. E. Simpson, T. J. Scialla, A. Bagg and M. Carroll: Survival of acute myeloid leukemia cells requires PI3 kinase activation. Blood 102, 972-980(2003) (Pubitemid 36917792)
77. Y. Liu, Y. Wang, M. Yamakuchi, S. Masuda, T. Tokioka, S. Yamaoka, I. Maruyama and I. Kitajima: Phosphoinositide-3 kinase-PKB/Akt pathway activation is involved in fibroblast Rat-1 transformation by human T-cell leukemia virus type I tax. Oncogene 20, 2514-2526(2001) (Pubitemid 32531348)
78. S. G. Ward, R. Parry, C. LeFeuvre, D. M. Sansom, J. Westwick and A. I. Lazarovits: Antibody ligation of CD7 leads to association with phosphoinositide 3-kinase and phosphatidylinositol 3, 4, 5-trisphosphate formation in T lymphocytes. Eur J Immunol 25, 502-507(1995)
79. D. M. Lee, D. D. Patel, A. M. Pendergast and B. F. Haynes: Functional association of CD7 with phosphatidylinositol 3-kinase: interaction via a YEDM motif. Int Immunol 8, 1195-1203(1996) (Pubitemid 26289898)
80. 2+ influx that eventually results in loss of CD7 expression and activation of an antiapoptotic pathway involving AKT and BAD which paves the way for malignant transformation. Leukemia 21, 788-796(2007) (Pubitemid 46444564)
81. Y. Morishima, M. Kobayashi, S. Y. Yang, N. H. Collins, M. K. Hoffmann and B. Dupont: Functionally different T lymphocyte subpopulations determined by their sensitivity to complement-dependent cell lysis with the monoclonal antibody 4A. J Immunol 129, 1091-1098(1982) (Pubitemid 12055576)
82. R. E. Ware, M. K. Hart and B. F. Haynes: Induction of T cell CD7 gene transcription by nonmitogenic ionomycininduced transmembrane calcium flux. J Immunol 147, 2787-2794(1991)
83. M. Rincon, A. Tugores and M. Lopez-Botet: Cyclic AMP and calcium regulate at a transcriptional level the expression of the CD7 leukocyte differentiation antigen. J Biol Chem 267, 18026-18031(1992)
84. T. Fujii, N. Ushiyama, K. Hosonuma, A. Suenaga and K. Kawashima: Effects of human antithymocyte globulin on acetylcholine synthesis, its release and choline acetyltransferase transcription in a human leukemic T-cell line. J Neuroimmunol 128, 1-8(2002) (Pubitemid 34722357)
85. 2+ homeostasis in the endoplasmic reticulum. Cell Death Differ 13, 1409-1418(2006) (Pubitemid 44057477)
86. S. Cory, D. C. Huang and J. M. Adams: The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 22, 8590-8607(2003) (Pubitemid 38028528)
87. 2+ homeostasis in the endoplasmic reticulum. Cell Death Differ 13, 1409-1418(2006) (Pubitemid 44057477)
88. 2+ signals according to the strength of T cell receptor activation. J Cell Biol 172, 127-137(2006) (Pubitemid 43042635)
89. R. Chen, I. Valencia, F. Zhong, K. S. McColl, H. L. Roderick, M. D. Bootman, M. J. Berridge, S. J. Conway, A. B. Holmes, G. A. Mignery, P. Velez and C. W. Distelhorst: Bcl-2 functionally interacts with inositol 1, 4, 5-trisphosphate receptors to regulate calcium release from the ER in response to inositol 1, 4, 5-trisphosphate. J Cell Biol 166, 193-203(2004) (Pubitemid 38988772)
90. M. Brini, D. Bano, S. Manni, R. Rizzuto and E. Carafoli: Effects of PMCA and SERCA pump overexpression on the kinetics of cell Ca (2+) signalling. EMBO J 19, 4926-4935(2000)
91. R. Rizzuto, P. Pinton, D. Ferrari, M. Chami, G. Szabadkai, P. J. Magalhaes, V. F. Di and T. Pozzan: Calcium and apoptosis: facts and hypotheses. Oncogene 22, 8619-8627(2003) (Pubitemid 38019197)
92. 2+ homeostasis in the endoplasmic reticulum. Cell Death Differ 13, 1409-1418(2006) (Pubitemid 44057477)
93. 2+ signals according to the strength of T cell receptor activation. J Cell Biol 172, 127-137(2006) (Pubitemid 43042635)
94. T. F. Franke, D. R. Kaplan and L. C. Cantley: PI3K: downstream AKTion blocks apoptosis. Cell 88, 435-437(1997) (Pubitemid 27154408)
95. J. Luo, B. D. Manning and L. C. Cantley: Targeting the PI3K-Akt pathway in human cancer: rationale and promise. Cancer Cell 4, 257-262(2003) (Pubitemid 37329790)
96. J. M. Albert, K. W. Kim, C. Cao and B. Lu: Targeting the Akt/mammalian target of rapamycin pathway for radiosensitization of breast cancer. Mol Cancer Ther 5, 1183-1189(2006) (Pubitemid 43881310)
97. P. L. del, M. Gonzalez-Garcia, C. Page, R. Herrera and G. Nunez: Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278, 687-689(1997) (Pubitemid 27464966)
98. M. Rudelius, S. Pittaluga, S. Nishizuka, T. H. Pham, F. Fend, E. S. Jaffe, L. Quintanilla-Martinez and M. Raffeld: Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma. Blood 108, 1668-1676(2006) (Pubitemid 44316136)
99. T. F. Franke, D. R. Kaplan and L. C. Cantley: PI3K: downstream AKTion blocks apoptosis. Cell 88, 435-437(1997) (Pubitemid 27154408)
100. I. D. Hiles, M. Otsu, S. Volinia, M. J. Fry, I. Gout, R. Dhand, G. Panayotou, F. Ruiz-Larrea, A. Thompson, N. F. Totty et al: Phosphatidylinositol 3-kinase: structure and expression of the 110 kd catalytic subunit. Cell 70, 419-429(1992)
101. A. E. Kelly-Welch, E. M. Hanson, M. R. Boothby and A. D. Keegan: Interleukin-4 and interleukin-13 signaling connections maps. Science 300, 1527-1528(2003) (Pubitemid 36686713)
102. V. Duronio, M. P. Scheid and S. Ettinger: Downstream signalling events regulated by phosphatidylinositol 3-kinase activity. Cell Signal 10, 233-239(1998) (Pubitemid 28205901)
103. T. F. Franke, D. R. Kaplan and L. C. Cantley: PI3K: downstream AKTion blocks apoptosis. Cell 88, 435-437(1997) (Pubitemid 27154408)
104. B. A. Hemmings: Akt signaling: linking membrane events to life and death decisions. Science 275, 628-630(1997) (Pubitemid 27061321)
105. Q. Xu, S. E. Simpson, T. J. Scialla, A. Bagg and M. Carroll: Survival of acute myeloid leukemia cells requires PI3 kinase activation. Blood 102, 972-980(2003) (Pubitemid 36917792)
106. Y. Liu, Y. Wang, M. Yamakuchi, S. Masuda, T. Tokioka, S. Yamaoka, I. Maruyama and I. Kitajima: Phosphoinositide-3 kinase-PKB/Akt pathway activation is involved in fibroblast Rat-1 transformation by human T-cell leukemia virus type I tax. Oncogene 20, 2514-2526(2001) (Pubitemid 32531348)
107. G. N. Vespa, L. A. Lewis, K. R. Kozak, M. Moran, J. T. Nguyen, L. G. Baum and M. C. Miceli: Galectin-1 specifically modulates TCR signals to enhance TCR apoptosis but inhibit IL-2 production and proliferation. J Immunol 162, 799-806(1999) (Pubitemid 29035402)
108. K. E. Pace, H. P. Hahn, M. Pang, J. T. Nguyen and L. G. Baum: CD7 delivers a pro-apoptotic signal during galectin-1-induced T cell death. J Immunol 165, 2331-2334(2000) (Pubitemid 30660673)
109. D. K. Hsu, C. A. Dowling, K. C. Jeng, J. T. Chen, R. Y. Yang and F. T. Liu: Galectin-3 expression is induced in cirrhotic liver and hepatocellular carcinoma. Int J Cancer 81, 519-526(1999) (Pubitemid 29203046)
110. L. Martins, S. E. Matsuo, K. N. Ebina, M. A. Kulcsar, C. U. Friguglietti and E. T. Kimura: Galectin-3 messenger ribonucleic acid and protein are expressed in benign thyroid tumors. J Clin Endocrinol Metab 87, 4806-4810(2002) (Pubitemid 35247079)
111. A. Yoshimura, A. Gemma, Y. Hosoya, E. Komaki, Y. Hosomi, T. Okano, K. Takenaka, K. Matuda, M. Seike, K. Uematsu, S. Hibino, M. Shibuya, T. Yamada, S. Hirohashi and S. Kudoh: Increased expression of the LGALS3 (galectin 3) gene in human non-small-cell lung cancer. Genes Chromosomes Cancer 37, 159-164(2003) (Pubitemid 36529783)
112. 2+ signalling". Biol Cell 96, 69-78(2004) (Pubitemid 38240400)
113. T. Fujii, N. Ushiyama, K. Hosonuma, A. Suenaga and K. Kawashima: Effects of human antithymocyte globulin on acetylcholine synthesis, its release and choline acetyltransferase transcription in a human leukemic T-cell line. J Neuroimmunol 128, 1-8(2002) (Pubitemid 34722357)
114. R. Rizzuto, P. Pinton, D. Ferrari, M. Chami, G. Szabadkai, P. J. Magalhaes, V. F. Di and T. Pozzan: Calcium and apoptosis: facts and hypotheses. Oncogene 22, 8619-8627(2003) (Pubitemid 38019197)